These interactions form a positive feedback loop that drives IGF2BP1 phase separation and promotes c-Myc and E2F1 signaling, cell cycle progression, and proliferation of NSCLC cells (Table 4). Here, E2F1 is linked to non-small cell lung carcinoma.